Nitric oxide metabolism is impaired by type 1 diabetes and diabetic nephropathy

  • Authors:
    • Jelizaveta Sokolovska
    • Alise Dekante
    • Larisa Baumane
    • Leonora Pahirko
    • Janis Valeinis
    • Kristine Dislere
    • Vita Rovite
    • Valdis Pirags
    • Nikolajs Sjakste
  • View Affiliations

  • Published online on: March 4, 2020     https://doi.org/10.3892/br.2020.1288
  • Pages: 251-258
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Diabetes leads to reduced nitric oxide bioavailability, resulting in endothelial dysfunction. However, overproduction of nitric oxide due to hyperglycaemia is associated with oxidative stress and tissue damage. The objective of this study was to characterise nitric oxide production (NO) and added nitrite and nitrate (NO2‑+NO3‑) concentration in the blood and urine of patients with and without diabetic nephropathy. A total of 268 patients with type 1 diabetes and 69 healthy subjects were included. Diabetic nephropathy was defined as macroalbuminuria and/or estimated glomerular filtration rate below 60 ml/min/1.73 cm2. NO2‑+NO3‑ concentration was measured by Griess reaction. Production of NO was detected by electron paramagnetic resonance spectroscopy. Blood NO was demonstrated to be higher (P<0.001) and serum NO2‑+NO3‑ was lower (P=0.003) in patients with type 1 diabetes and no nephropathy vs. healthy subjects. However, serum NO2‑+NO3‑ concentration in patients with diabetes and nephropathy did not differ from the levels observed in healthy controls. Urine excretion of NO2‑+NO3‑ was significantly decreased in patients with nephropathy, compared with patients without diabetic kidney disease (P=0.006) and healthy subjects (P=0.010). A significant positive correlation was observed between urine NO2‑+NO3‑ and estimated glomerular filtration rate in patients with type 1 diabetes (P=0.002) and healthy subjects (P=0.008). Estimated glomerular filtration rate, albuminuria and diabetic nephropathy status were significant predictors of the whole blood NO and NO2‑+NO3‑ in serum and urine in patients with type 1 diabetes, as identified by linear regression models. The present study concludes that NO metabolism is impaired by type 1 diabetes and diabetic nephropathy.

Related Articles

Journal Cover

May 2020
Volume 12 Issue 5

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Sokolovska, J., Dekante, A., Baumane, L., Pahirko, L., Valeinis, J., Dislere, K. ... Sjakste, N. (2020). Nitric oxide metabolism is impaired by type 1 diabetes and diabetic nephropathy. Biomedical Reports, 12, 251-258. https://doi.org/10.3892/br.2020.1288
MLA
Sokolovska, J., Dekante, A., Baumane, L., Pahirko, L., Valeinis, J., Dislere, K., Rovite, V., Pirags, V., Sjakste, N."Nitric oxide metabolism is impaired by type 1 diabetes and diabetic nephropathy". Biomedical Reports 12.5 (2020): 251-258.
Chicago
Sokolovska, J., Dekante, A., Baumane, L., Pahirko, L., Valeinis, J., Dislere, K., Rovite, V., Pirags, V., Sjakste, N."Nitric oxide metabolism is impaired by type 1 diabetes and diabetic nephropathy". Biomedical Reports 12, no. 5 (2020): 251-258. https://doi.org/10.3892/br.2020.1288